Balkchyan Ane A, Nakamura Tiffany, Murray Stuart B
Department of Psychiatry and the Behavioral Sciences, University of Southern California, Los Angeles, California, USA.
Eat Disord. 2022 Mar-Apr;30(2):144-153. doi: 10.1080/10640266.2022.2064109. Epub 2022 Apr 20.
An array of novel and important studies advancing the treatment of eating disorders (EDs) were published in in 2021. In an unprecedented year of challenges to the delivery of ED treatment, and the volume of patients requiring it, this review summarizes the recent contributions to the literature on the treatment of EDs. Notably, an emphasis on assessing and addressing barriers to collaborative care offers much promise in augmenting treatment delivery and patient outcomes. In keeping with recent data illustrating an elevated risk for increased symptom severity during the COVID-19 pandemic, a focus on further disseminating treatments to higher level of care settings will be critical as the field meets the challenge presented by COVID-19. In addition, we review recent findings relating to the broader assessment and treatment of comorbidities which exacerbate ED symptom severity-which offer critical insights into the development of novel treatments. These recent contributions pave the way for more nuanced approaches to treating EDs across the diagnostic spectrum.
2021年发表了一系列推进饮食失调（EDs）治疗的新颖且重要的研究。在ED治疗的提供面临前所未有的挑战以及需要治疗的患者数量众多的这一年里，本综述总结了近期文献中对EDs治疗的贡献。值得注意的是，强调评估和解决协作护理的障碍在加强治疗提供和改善患者结局方面大有希望。鉴于最近的数据表明在COVID-19大流行期间症状严重程度增加的风险升高，随着该领域应对COVID-19带来的挑战，将治疗进一步推广到更高水平的护理环境将至关重要。此外，我们回顾了近期与共病的更广泛评估和治疗相关的发现，这些共病会加剧ED症状的严重程度，为新型治疗方法的开发提供了关键见解。这些近期的贡献为跨诊断范围治疗EDs的更细致入微的方法铺平了道路。
